77 related articles for article (PubMed ID: 189778)
1. Intravenous fat tolerance. Correlation with very low density lipoprotein apoprotein B kinetics in man.
Nicoll A; Sigurdsson G; Marsh A; Lewis B
Atherosclerosis; 1977 Jan; 26(1):17-22. PubMed ID: 189778
[TBL] [Abstract][Full Text] [Related]
2. Catabolism of very low density lipoprotein B apoprotein in man.
Reardon MF; Fidge NH; Nestel PJ
J Clin Invest; 1978 Mar; 61(3):850-60. PubMed ID: 205554
[TBL] [Abstract][Full Text] [Related]
3. Suppression by diets rich in fish oil of very low density lipoprotein production in man.
Nestel PJ; Connor WE; Reardon MF; Connor S; Wong S; Boston R
J Clin Invest; 1984 Jul; 74(1):82-9. PubMed ID: 6736254
[TBL] [Abstract][Full Text] [Related]
4. Impaired very low density lipoprotein and triglyceride removal in broad beta disease: comparison with endogenous hypertriglyceridemia.
Chait A; Hazzard WR; Albers JJ; Kushwaha RP; Brunzell JD
Metabolism; 1978 Sep; 27(9):1055-66. PubMed ID: 210351
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects.
Huff MW; Fidge NH; Nestel PJ; Billington T; Watson B
J Lipid Res; 1981 Nov; 22(8):1235-46. PubMed ID: 7320634
[TBL] [Abstract][Full Text] [Related]
6. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus.
Kissebah AH; Alfarsi S; Evans DJ; Adams PW
Diabetes; 1982 Mar; 31(3):217-25. PubMed ID: 7152129
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
Kashyap ML; Srivastava LS; Chen CY; Perisutti CG; Campbell M; Lutmer RF; Glueck CJ
J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
[TBL] [Abstract][Full Text] [Related]
8. Turnover of very low-density lipoprotein-apoprotein B is increased by substitution of soybean protein for meat and dairy protein in the diets of hypercholesterolemic men.
Huff MW; Giovannetti PM; Wolfe BM
Am J Clin Nutr; 1984 Jun; 39(6):888-97. PubMed ID: 6539062
[TBL] [Abstract][Full Text] [Related]
9. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy.
Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V
Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185
[TBL] [Abstract][Full Text] [Related]
10. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes.
Ericsson M; Johnson O; Tollin C; Furberg B; Backman C; Angquist K
Scand J Rehabil Med; 1982; 14(4):209-12. PubMed ID: 7178868
[TBL] [Abstract][Full Text] [Related]
11. Further methodological studies on the intravenous fat tolerance with Intralipid emulsion.
Rössner S
Scand J Clin Lab Invest; 1976 Mar; 36(2):155-9. PubMed ID: 1273493
[TBL] [Abstract][Full Text] [Related]
12. Effects of dietary saturated and polyunsaturated fat on the metabolism of apolipoproteins A-I and B. Study of a patient with type IIb hyperlipoproteinaemia.
Shepherd J; Packard CJ; Gotto AM; Taunton OD
Clin Chim Acta; 1978 Aug; 87(3):395-404. PubMed ID: 209911
[TBL] [Abstract][Full Text] [Related]
13. Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus.
Vergès B; Guiu B; Cercueil JP; Duvillard L; Robin I; Buffier P; Bouillet B; Aho S; Brindisi MC; Petit JM
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3050-7. PubMed ID: 23087360
[TBL] [Abstract][Full Text] [Related]
14. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Chan DC; Watts GF; Nguyen MN; Barrett PH
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
[TBL] [Abstract][Full Text] [Related]
15. Increased low-density-lipoprotein catabolism in myeloproliferative disorders.
Ginsberg H; Gilbert HS; Gibson JC; Le NA; Brown WV
Ann Intern Med; 1982 Mar; 96(3):311-6. PubMed ID: 7059093
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia.
Shahmanesh M; Das S; Stolinski M; Shojaee-Moradie F; Jackson NC; Jefferson W; Cramb R; Nightingale P; Umpleby AM
J Clin Endocrinol Metab; 2005 Feb; 90(2):755-60. PubMed ID: 15522931
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of apoprotein B in cynomolgus monkey: evidence for independent production of low-density lipoprotein apoprotein B.
Goldberg IJ; Le NA; Ginsberg HN; Paterniti JR; Brown WV
Am J Physiol; 1983 Feb; 244(2):E196-201. PubMed ID: 6824074
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of very low density lipoproteins in hyperlipidaemia: studies of apolipoprotein B kinetics in man.
Sigurdsson G; Nicoll A; Lewis B
Eur J Clin Invest; 1976 Mar; 6(2):167-77. PubMed ID: 177296
[TBL] [Abstract][Full Text] [Related]
19. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
Kushwaha RS; Chait A; Hazzard WR
J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
Ginsberg HN; Le NA; Gibson JC
J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
